NCT01312389 A Clinical Trial of Autologous Oxidized Tumor Cell Lysate Vaccine For Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT00215800 The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome Status COMPLETED Phase PHASE3
NCT00002269 A Multicenter, Double-Blind, Controlled Study to Evaluate Ampligen Status COMPLETED Phase NA
NCT00001000 A Study of Atvogen in Healthy Volunteers and HIV-Infected Patients Who Have No Symptoms of Infection Status COMPLETED Phase NA
NCT00000735 A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC Status COMPLETED Phase PHASE1
NCT00000713 A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects Status COMPLETED Phase PHASE1